{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:54:23Z","timestamp":1781747663559,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.14283\/jpad.2024.154","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:49:44Z","timestamp":1722516584000},"page":"1809-1817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"E.","family":"Vijverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Scheijbeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Hamby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grundman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony O.","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.14283\/jpad.2024.154_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer's brain","volume":"154","author":"Li","year":"2020","journal-title":"J Neurochem"},{"issue":"11","key":"10.14283\/jpad.2024.154_bib2","doi-asserted-by":"crossref","first-page":"e111898","DOI":"10.1371\/journal.pone.0111898","article-title":"Alzheimer's therapeutics targeting amyloid beta 1\u201342 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.14283\/jpad.2024.154_bib3","doi-asserted-by":"crossref","first-page":"e111899","DOI":"10.1371\/journal.pone.0111899","article-title":"Alzheimer's therapeutics targeting amyloid beta 1\u201342 oligomers II: Sigma-2\/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.14283\/jpad.2024.154_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","article-title":"AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss","volume":"52","author":"Hsieh","year":"2006","journal-title":"Neuron"},{"issue":"4","key":"10.14283\/jpad.2024.154_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J Neurosci"},{"issue":"11","key":"10.14283\/jpad.2024.154_bib6","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the alzheimer amyloid-protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J Neurosci"},{"issue":"22","key":"10.14283\/jpad.2024.154_bib7","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-\u03b2 oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO J"},{"issue":"8","key":"10.14283\/jpad.2024.154_bib8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/alz.12302","article-title":"Preclinical and clinical biomarker studies of CT1812: a novel approach to Alzheimer's disease modification","volume":"17","author":"Izzo","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40035-023-00358-w","article-title":"A phase 1b randomized clinical trial of CT1812 to measure A\u03b2 oligomer displacement in Alzheimer's disease using an indwelling CSF catheter","volume":"12","author":"LaBarbera","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"7","key":"10.14283\/jpad.2024.154_bib10","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.3390\/ijms24076251","article-title":"Sigma-2 receptors-from basic biology to therapeutic target: A focus on age-related degenerative diseases","volume":"24","author":"Lizama","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.14283\/jpad.2024.154_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/acsmedchemlett.1c00048","article-title":"Discovery of investigational drug CT1812, an antagonist of the sigma-2 receptor complex for Alzheimer's disease","volume":"12","author":"Rishton","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.14283\/jpad.2024.154_bib12","doi-asserted-by":"crossref","first-page":"1291881","DOI":"10.3389\/fnagi.2023.1291881","article-title":"Association of plasma amyloid-\u03b2 oligomerization with theta\/beta ratio in older adults","volume":"15","author":"Bae","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-020-00632-3","article-title":"Reproducibility of EEG functional connectivity in Alzheimer's disease","volume":"12","author":"Briels","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.14283\/jpad.2024.154_bib14","doi-asserted-by":"crossref","first-page":"1008.e25","DOI":"10.1016\/j.neurobiolaging.2011.10.013","article-title":"Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics","volume":"33","author":"de Waal","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2024.154_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2017.05.017","article-title":"EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects","volume":"57","author":"Gouw","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.14283\/jpad.2024.154_bib16","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","article-title":"EEG dynamics in patients with Alzheimer's disease","volume":"115","author":"Jeong","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13195-018-0431-6","article-title":"Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study","volume":"10","author":"Scheltens","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-2012-121189","article-title":"Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial","volume":"31","author":"Scheltens","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.14283\/jpad.2024.154_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10072-023-07114-y","article-title":"The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review","volume":"45","author":"Arjmandi-Rad","year":"2024","journal-title":"Neurol Sci"},{"issue":"6","key":"10.14283\/jpad.2024.154_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-2003-45118","article-title":"Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial","volume":"36","author":"Brassen","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.14283\/jpad.2024.154_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000054902","article-title":"Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients","volume":"43","author":"Adler","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.14283\/jpad.2024.154_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fneur.2016.00161","article-title":"Magnetoencephalography for the detection of intervention effects of a specific nutrient combination in patients with mild Alzheimer's Disease: Results from an exploratory doubleblind, randomized, controlled study","volume":"7","author":"van Straaten","year":"2016","journal-title":"Front Neurol"},{"key":"10.14283\/jpad.2024.154_bib23","doi-asserted-by":"crossref","first-page":"102711","DOI":"10.1016\/j.nicl.2021.102711","article-title":"Resting-state electroencephalographic biomarkers of Alzheimer's disease","volume":"31","author":"Cecchetti","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"9","key":"10.14283\/jpad.2024.154_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/alz.12311","article-title":"Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel","volume":"17","author":"Babiloni","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clinph.2019.09.014","article-title":"In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer's disease","volume":"131","author":"Briels","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.14283\/jpad.2024.154_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2019.09.008","article-title":"What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons","volume":"85","author":"Babiloni","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13195-023-01327-1","article-title":"Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer's disease continuum: considerations for clinical trials","volume":"15","author":"Scheijbeler","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.154_bib28","doi-asserted-by":"crossref","unstructured":"Cummings J, Kinney J, Fillit H. Alzheimer's Disease Drug Development: Research and Development Ecosystem. 2022, Chapter 36","DOI":"10.1017\/9781108975759"},{"key":"10.14283\/jpad.2024.154_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.trci.2018.11.001","article-title":"A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease","volume":"5","author":"Grundman","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2024.154_bib30","article-title":"An interim exploratory biomarker analysis of a Phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease","author":"Lizama","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.14283\/jpad.2024.154_bib31","first-page":"1","article-title":"The allosteric antagonist of the sigma-2 receptors-elayta (CT1812) as a therapeutic candidate for mild to moderate Alzheimer's disease: A Scoping Systematic Review","volume":"13","author":"Rasheed","year":"2022","journal-title":"Life (Basel)"},{"issue":"4","key":"10.14283\/jpad.2024.154_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"13","key":"10.14283\/jpad.2024.154_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.14283\/jpad.2024.154_bib34","series-title":"Clinical Gerontology: A Guide to Assessment and Intervention","first-page":"165","article-title":"Geriatric Depression Scale (GDS): recent evidence and development of a shorter version","author":"Sheikh","year":"1986"},{"issue":"2","key":"10.14283\/jpad.2024.154_bib35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuroimage.2012.03.048","article-title":"Measuring functional connectivity in MEG: a multivariate approach insensitive to linear source leakage","volume":"63","author":"Brookes","year":"2012","journal-title":"Neuroimage"},{"issue":"7","key":"10.14283\/jpad.2024.154_bib36","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/00001756-200005150-00029","article-title":"Amplitude envelope correlation detects coupling among incoherent brain signals","volume":"11","author":"Bruns","year":"2000","journal-title":"NeuroReport"},{"issue":"6","key":"10.14283\/jpad.2024.154_bib37","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nn.3101","article-title":"Large-scale cortical correlation structure of spontaneous oscillatory activity","volume":"15","author":"Hipp","year":"2012","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.14283\/jpad.2024.154_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-170991","article-title":"The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review","volume":"63","author":"Kueper","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"Suppl2","key":"10.14283\/jpad.2024.154_bib39","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"12","key":"10.14283\/jpad.2024.154_bib40","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.14283\/jpad.2024.154_bib41","unstructured":"Pandey K, Duong D, Waybright L, et al. Pharmacodynamic effects of the S2R modulator CT1812 in Alzheimer's disease patients observed in a meta-analysis of CSF proteomes from SPARC and SHINE Part A. Poster presented at: AD\/PD\u2122 2023 International Conference on Alzheimer's and Parkinson's Diseases"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724007106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724007106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:17:39Z","timestamp":1737339459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724007106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2274580724007106"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.154","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}